Injecting Wegovy in the Stomach: What the Evidence Says About Site, Technique and Results

The abdomen, thigh and upper arm are all licensed injection sites for Wegovy — the stomach is the site used most often in practice and throughout the major clinical trials.
Rotating the exact spot within the stomach (keeping at least 2–3 cm from the navel and any previous injection point) reduces the risk of lipodystrophy and keeps absorption consistent.
The pen should be held firmly against clean, dry skin at a 90-degree angle; the needle does not need to be visible before or after injection.
Wegovy is a once-weekly injection — injecting it more frequently than prescribed will not increase results and increases the risk of side effects.

The abdomen is the most studied injection site for semaglutide: clinical trials including the STEP 1 programme used the stomach, thigh and upper arm interchangeably, and the NHS patient information for semaglutide confirms all three as licensed options. Injecting Wegovy in the stomach is widely used because the tissue there is usually easy to reach, straightforward to pinch up, and the site can be rotated across a generous area. Wegovy is a prescription-only medicine; a GPhC-registered prescriber must assess your suitability before treatment begins, and your Patient Information Leaflet is the definitive guide for your specific dose and pen.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

Stomach injection technique, site rotation and what the clinical evidence tells us

What the STEP trials established about abdominal injection

The STEP 1 trial (published in the New England Journal of Medicine) randomised nearly 2,000 adults with obesity to 2.4mg semaglutide or placebo over 68 weeks, with participants self-injecting weekly into the abdomen, thigh or upper arm. Average weight reduction in the semaglutide group reached around 15% of body weight. That result was not attributed to any single injection site: all three were treated as equivalent. What the trial did reinforce is that consistent weekly dosing, correct technique and rotating the injection point each week are the practical variables that matter. The Wegovy SmPC (available on the Electronic Medicines Compendium) formalises this: subcutaneous injection into any of the three sites is licenced, and patients should change the exact location within a site each time.

The stomach is popular for a practical reason: most people can pinch up an inch of subcutaneous tissue there without difficulty, which is what the technique requires. Upper arm self-injection is harder to perform without assistance; the thigh works well but can feel firmer. Neither is medically superior to the abdomen, but the abdomen's accessibility makes it the default for most self-injecting patients.

Finding the right spot on your stomach and rotating it properly

The licensed injection zone on the stomach is the lower abdomen, roughly the area between the hip bones, staying at least 2–3 cm away from the navel. Injecting too close to the navel can be more painful and may affect absorption. The area around a scar, broken skin or any area that is tender, bruised or hardened from previous injections should be avoided each week.

Rotation matters more than most people expect. Injecting repeatedly into the same small patch of skin can cause lipodystrophy, localised lumps or indentations in the fatty tissue that alter how the medicine is absorbed. A simple way to keep track is to move clockwise around the injection zone: left side of the stomach one week, right side the next, working slightly above or below the previous spot. Our guide to exactly where on the stomach to inject Wegovy covers this rotation pattern in more detail, with diagrams of the recommended zone.

Skin should be clean and dry before you inject. An alcohol swab can be used to clean the area, let it dry fully before injecting, since alcohol on the skin can cause a brief stinging sensation when the needle goes in.

Step-by-step: how the injection itself works

The Wegovy pen is pre-filled and pre-set to your current dose; there is no need to dial a number or attach a separate needle for most pen formats. Here is the general sequence, consistent with NHS and SmPC guidance, your own Patient Information Leaflet takes precedence for your specific device.

First, take the pen from the fridge and let it come to room temperature for around 30 minutes. Cold medicine can be more uncomfortable going in. Check the pen window to confirm the liquid is clear and colourless. Remove the pen cap. Pinch up a fold of skin at the chosen stomach site. Place the pen flat against the skin at a 90-degree angle, press firmly down, and activate the injection button. Hold the pen in place (most people count slowly to ten) before removing it. You should hear or feel a click when the dose has been delivered. If you would like more detail on the abdominal approach specifically, our page on how to inject Wegovy in the stomach walks through each consideration for that site. For a visual walkthrough of the technique, this step-by-step video guide runs through each stage of the process.

Used pens contain a retracted needle and must be disposed of in a sharps container, not in household waste. Most community pharmacies will accept sealed sharps containers for disposal.

Side effects to expect and when to get medical help

The most common side effects after injecting Wegovy are gastrointestinal: nausea, diarrhoea, constipation, reflux and burping. These are typically most noticeable after starting or stepping up to a new dose, and they tend to ease within one to two weeks as the body adjusts. Injection-site reactions (brief redness, itching or a small lump) are also common and usually settle quickly, particularly with good rotation practice. If you are taking the unbranded form of the medicine, our guidance on how to give a semaglutide injection in the stomach covers the same principles with wording that reflects the generic product.

Seek medical help promptly if you develop severe stomach pain that spreads to your back, with or without vomiting. The MHRA issued a Drug Safety Update in January 2026 flagging acute pancreatitis as a known, though infrequent, side effect of GLP-1 medicines that warrants urgent attention. You can report any suspected side effect through the MHRA Yellow Card scheme. Other signs that need prompt review include symptoms of a serious allergic reaction, signs of dehydration from severe vomiting or diarrhoea, or any symptoms you are uncertain about. If in doubt, contact your prescriber or call 111, our support team is also available seven days a week for aftercare queries. On the subject of cost or switching provider, a plain overview of where Wegovy is available in the UK covers the private and NHS routes without the sales pressure.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions